SCHEMBL8830987

SCHEMBL8830987

COC(=O)[C@@H]1CC(OS(C)(=O)=O)CN1C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.49
ANPEP P15144 1/20 0.49
POLB P06746 1/20 0.48
FKBP1A P62942 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MAPT P10636 2/20 0.42
MITF O75030 1/20 0.42
HTT P42858 1/20 0.42
PREP P48147 2/20 0.41
RAB9A P51151 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
MMP1 P03956 1/20 0.41
MMP3 P08254 1/20 0.41
MMP7 P09237 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2317032 1.00 MMP2 (0.49) MMP2ANPEPPOLBFKBP1ANPSR1
SCHEMBL15399060 1.00 MMP2 (0.49) MMP2ANPEPPOLBFKBP1ANPSR1
SCHEMBL7734259 1.00 MMP2 (0.49) MMP2ANPEPPOLBFKBP1ANPSR1
SCHEMBL9521198 0.90 POLB (0.48) POLBPREPRAB9ANPC1SMN1; SMN2
SCHEMBL9428692 0.89 MMP2 (0.50) MMP2ANPEPPOLBNPSR1HTT
SCHEMBL7805540 0.89 MMP2 (0.50) MMP2ANPEPPOLBNPSR1HTT
SCHEMBL24065124 0.89 POLB (0.43) MMP2ANPEPPOLBFKBP1ANPSR1
SCHEMBL7149261 0.89 POLB (0.43) MMP2ANPEPPOLBPTPN1
SCHEMBL2999647 0.88 POLB (0.49) MMP2POLBFKBP1ANPSR1MAPT
SCHEMBL9098331 0.88 POLB (0.49) MMP2POLBFKBP1ANPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7118243-A None JP disclosed
US-20220308043-A1 FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-09-29 US disclosed
US-5623049-A FLEXIBLE ANTISENSE AGENTS COMPRISING OLIGONUCEOTIDES HAVING THE (DEOXY)RIBOSE BACKBONE REPLACED BY AN OLIGOPEPTIDE; PROTEASE- AND NUCLEASE-RESISTANT; VIRICIDES; ATTACHED TO CARRIERS ABLE TO PENETRATATE IN CELLS BAYER AKTIENGESELLSCHAFT (DE) 1997-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220308043-A1 FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO ABCB11, SLC10A1, SLC10A2 MMP2 1180/4885ANPEP 1690/4885POLB 3442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.